Otitis media with effusion
Conditions
Interventions
Eustachian tube inflation atomization group (Children group):The treatment was given twice a day for 5 days, or stopped because of intolerance (pain or acute upper respiratory tract infection), if it
Eustachian tube inflation atomization group (Adult group):The treatment was given twice a day for 5 days, or stopped because of intolerance (pain or acute upper respiratory tract infection), if it rec
Eustachian tube inflation group (Children group):The Eustachian tube inflation group used an electric Eustachian tube inflation device. 2 times a day, 10 minutes a time
The duration of inflation was up to 12 weeks and either stopped because of intolerance (pain or acute upper respiratory tract infection) or healed (healed was defined as bone-air gap =5dB on pure tone
Eustachian tube inflation group(Adult group):The Eustachian tube inflation group used an electric Eustachian tube inflation device. 2 times a day, 10 minutes a time
Drug group (Children group):Mometasone furoate nasal spray (Nesonar, 60 pug /140
Sponsors
Shandong Second People's Hospital
Eligibility
Sex/Gender
All
Age
4 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. good general health and clear consciousness; 2. provide signed and dated informed consent; 3. express willingness to comply with all study procedures and availability during the study period; 4. Age: children (4-12 years old), adults (18-70 years old), both sexes; 5. Course of disease: the duration of onset was within 4 weeks; 6. hearing loss, pure tone audiometry showed that the air conduction hearing level (500Hz, 1kHz, 2kHz, 4kHz average threshold) decreased by more than 20dB; Or tympanic effusion in otoendoscopy examination; 7. Tympanogram showed type B, C1 or C2;
Exclusion criteria
Exclusion criteria: 1. recent nasal, sinusitis or upper respiratory tract infection, and retrograde ear infection; 2. patients with congenital or secondary Eustachian tube atresia; 3. patients with nasopharyngeal tumors, nasopharyngeal carcinoma and systemic malignant tumors; 4. patients with adenoid hypertrophy; 5. patients with patulous Eustachian tube; 6. recent nasal or nasopharynx bleeding; 7. with cleft lip and palate and unable to seal the nasopharyngeal cavity; 8. vocal fold spasm or paralysis; 9. patients with recent middle ear surgery; 10. during pregnancy or lactation; 11. combined with other diseases, antibiotics or hormone drugs should be taken.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| hearing result; | — |
Secondary
| Measure | Time frame |
|---|---|
| Effusion in the tympanic cavity;Eustachian tube function;Degree of ear fullness; | — |
Countries
China
Contacts
Public ContactLi Li
Shandong Second People's Hospital
Outcome results
None listed